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Abstract
Background: Adequate consumption of polyunsaturated fatty acids (PUFA) is vital for normal development and
functioning of the central nervous system. The long-chain n-3 PUFAs docosahexaenoic acid (DHA) and
eicosapentaenoic acid are anti-inflammatory and neuroprotective in the models of central nervous system injury
including traumatic brain injury (TBI). In the present study, we tested whether a higher brain DHA status in a mouse
model on an adequate dietary α-linolenic acid (ALA) leads to reduced neuroinflammation and improved
spontaneous recovery after TBI in comparison to a moderately lowered brain DHA status that can occur in humans.
Methods: Mice reared on diets with differing ALA content were injured by a single cortical contusion impact.
Change in the expression of inflammatory cytokines was measured, and cellular changes occurring after injury were
analyzed by immunostaining for macrophage/microglia and astrocytes. Behavioral studies included rotarod and
beam walk tests and contextual fear conditioning.
Results: Marginal supply (0.04 %) of ALA as the sole dietary source of n-3 PUFA from early gestation produced
reduction of brain DHA by 35 % in adult offspring mice in comparison to the mice on adequate ALA diet (3.1 %).
The DHA-depleted group showed significantly increased TBI-induced expression of pro-inflammatory cytokines TNF-
α, IL-1β, and IL-6 in the brain as well as slower functional recovery from motor deficits compared to the adequate
ALA group. Despite the reduction of pro-inflammatory cytokine expression, adequate ALA diet did not significantly
alter either microglia/macrophage density around the contusion site or the relative M1/M2 phenotype. However,
the glial fibrillary acidic protein immunoreactivity was reduced in the injured cerebral cortex of the mice on
adequate ALA diet, indicating that astrocyte activation may have contributed to the observed differences in cellular
and behavioral responses to TBI.
Conclusions: Increasing the brain DHA level even from a moderately DHA-depleted state can reduce
neuroinflammation and improve functional recovery after TBI, suggesting possible improvement of functional
outcome by increasing dietary n-3 PUFA in human TBI.
Keywords: Polyunsaturated fatty acids (PUFA), Docosahexaenoic acid (DHA), Alpha-linolenic acid (ALA), Traumatic
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Background
Modern dietary practice has resulted in an increased
consumption of n-6 polyunsaturated fatty acids (PUFA)
with a corresponding deficit in n-3 PUFA. This
phenomenon has skewed the n-6 to n-3 PUFA ratio,
which is about 15:1 in modern diets [1]. Neuronal mem-
branes preferentially incorporate docosahexaenoic acid
(DHA; 22:6n-3), and its deficiency leads to altered gene
expression in the mouse brain [2]. As the brain tissue
content of DHA depends on the amount of n-3 PUFA in
the diet, decreased n-3 PUFA consumption would trans-
late to DHA deficiency in the brain. DHA deficiency
results in increased n-6 docosapentaenoic acid (DPAn-6;
22:5n-6) in the brain as a substitute for DHA. Mice
reared on adequate n-3 PUFA diet have very low levels
of DPAn-6 in the brain (with the approximate DPAn-6
to DHA ratio less than 0.01), which increases in mice on
low n-3 PUFA diet with a corresponding decrease in
DHA [3]. Therefore, the relative concentration of DPAn-
6 in the neural membrane may be used as an index of
DHA deficiency. Interestingly, significant amount of
DPAn-6 has been detected in the human brain with the
DPAn-6 to DHA ratio in the phospholipids of about
0.44 [4]. Assuming that the DHA/DPAn-6 proportion in
mice extrapolates to humans, this indicates that modern
human brains may not have the optimum DHA levels.
In addition to their role in development, n-3 PUFA, es-
pecially DHA and eicosapentaenoic acid (EPA; 20:5n-3),
have been shown to regulate immunity [5]. Dysregulated
inflammation is an important pathological factor in
models of central nervous system injury. Inflammatory re-
sponses in the brain have been attributed to local cellular
responses wherein glial cells, in particular, secrete pro-
inflammatory cytokines and chemokines. Under the influ-
ence of chemokines, there is an influx of neutrophils and
monocytes/macrophages into the brain tissue parenchyma
facilitated by a state of non-selective permeability brought
about by the disruption of the blood-brain barrier [6, 7].
The invading neutrophils, macrophages, and resident glial
cells produce both pro- and anti-inflammatory cytokines
such as interleukin (IL)-1β, tumor necrosis factor (TNF)-
α, IL-6, and IL-10 [8].
Pre-treatment with n-3 PUFA confers resilience and
protects against brain injury [9–11]. Administration of
these fatty acids has also been reported to be neuropro-
tective after stroke [12] and reduce axonal damage after
spinal cord injury [13, 14] and head injury [15]. We re-
cently reported impaired recovery from traumatic brain
injury (TBI) in mice that were severely depleted in brain
DHA (~70 %) [16]. DHA deficiencies of this magnitude
are not expected to be present in humans. However,
brain DHA levels can be lower if the n-3 PUFA intake is
insufficient, as in the case of infants fed with formula
milk lacking n-3 PUFA showing lower levels of brain
DHA than those on breast milk [17, 18]. In this study,
we sought to generate higher DPAn-6 to DHA ratio in
mouse brains similar to that in humans by providing low
level of α-linolenic acid (ALA; 18:3n-3) in the diet for
4 months from late gestation. Their cellular and behav-
ioral responses to TBI were compared to those of mice
on adequate ALA diet which resulted in higher levels of
brain DHA and only trace amount of DPAn-6.
Methods
A mouse model of low and adequate n-3 PUFA
Pregnant (E14) C57BL6/N mice purchased from Charles
River were placed on a diet containing a low ALA content
(0.04 %). The adequate n-3 PUFA group received a diet
containing flaxseed oil as a source of ALA (3.1 % ALA)
(Table 1). The fatty acid content of the diet is shown in
Table 2. Male offspring were reared on the same low or
adequate ALA diet till 4 months of age. The normal 12-h
light period was maintained in the animal housing facility,
and mice had free access to food and water.
TBI model
A single controlled cortical impact was delivered to the
exposed brain as previously reported [16]. Mice were
anesthetized with 5 % isoflurane and then maintained
under anesthesia at 2.5–3 % isoflurane during surgery.
The mouse head was fixed in a stereotaxic apparatus. A
~4 mm craniotomy was made with a drill over the left
cerebral hemisphere between the bregma and lambda
and the stereotaxic apparatus angled to make the plane
of the dura perpendicular to the impact. The flat-tipped
3-mm-diameter pin of the precision TBI head impactor
delivered a pneumatically controlled impact at 3.5 m/s
velocity with 1.5 mm penetration. The injury site was
covered with Surgicel and the craniotomy sealed with a
plastic cap glued using cyanoacrylate. The incision was
glued and a topical analgesic cream (EMLA) was applied
for analgesia. Lidocaine jelly was instilled in the ears,
and the mouse was placed in a cage over a hot water
blanket at 37 °C.
Fatty acid analysis
The contralateral cerebral hemisphere of the brains from
5-month-old mice was homogenized in 1:1 volumes of
methanol/butylated hydroxytoluene and Tris buffer (pH
7.4) for lipid extraction by the Bligh-Dyer method [19].
Table 1 Fatty acid sources in diets




Tocopherol-stripped safflower oil 19 17.7
Flaxseed oil 0 4.81
Hydrogenated coconut oil 81 77.49
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Chloroform and water were added to the homogenate to
attain a chloroform to methanol to water ratio of 2:2:1.8.
The homogenate was vortexed after displacing the air by
nitrogen to prevent oxidation and centrifuged at
3000 rpm at 4 °C. The organic layers were collected, and
the aqueous layer was treated for repeated extraction as
above. The lipids were transmethylated at 100 °C for 2 h
under nitrogen using borontrifluoride and methanol, and
fatty acids were analyzed by gas chromatography [20].
qRT-PCR
At 4 h, 24 h, or 4 days after TBI, mice were deeply anesthe-
tized with isoflurane and perfused quickly with chilled
phosphate-buffered saline under continued anesthesia. The
brain was removed, and the peri-contusional cortex was
dissected and immediately immersed in RNAlater solution
to preserve RNA integrity. The RNA was isolated using
TRIzol and reverse transcribed using Applied Biosystems
cDNA Reverse Transcription kit (Fisher Scientific,
Waltham, MA, USA) and amplified using QuantiTect SYBR
PCR kit (Qiagen, Valencia, CA, USA). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an internal
control to normalize the gene expression levels. The gene
expression changes are displayed relative to the respective
control (sham) level.









Chemokine (C–C motif ) ligand 2 (CCL2): forward 5′-
GGATCGGAACCAAATGAGAT-3′, reverse 5′-ATTT
ACGGGTCAACTTCACA-3′














Mice were perfused with chilled phosphate-buffered saline
(PBS) at 4 h, 24 h, and 4 days after TBI. The peri-
contusional cortex was carefully dissected and homoge-
nized in Tris-based lysis buffer containing protease inhibi-
tors, sonicated and centrifuged at 4 °C at 12,000 rpm for
15 min. The supernatant was collected and stored at −80 °
C until analysis. A commercial CCL2 ELISA kit (Raybio-
tech, Norcross, GA, USA), which is a colorimetry-based
sandwich ELISA kit, was used to quantify the CCL2
protein expression according to the manufacturer’s in-
structions. For the western blotting, samples were run in
pre-formed 4–12 % gradient gels, transferred to polivinyli-
dene difluride membrane, and incubated with mouse anti-
IL-1β antibody (Cell Signaling Technology, Danvers, MA,
USA). Bands were visualized and quantified to assess the
relative changes in expression of IL-1β using a Kodak Gel
Logic 440 imaging system with ImageQuant 5.1 software
(Molecular Dynamics, Sunnyvale, CA).
Immunofluorescence
At 3 days after TBI, the injured mice were perfused with
chilled PBS and then with 4 % paraformaldehyde. The
brains were immersed in paraformaldehyde for 24 h and
subsequently dehydrated with ethanol and permeated/em-
bedded with paraffin. Six-micrometer-thick sections were
cut with a cryotome and mounted on charged slides. Four
sections from the injury epicenter for each brain were later
deparaffinized, subjected to antigen retrieval by boiling in
citrate buffer for 20 min, and blocked with 5 % goat serum
for 1 h at room temperature. They were then incubated
overnight at 4 °C in anti-ionized calcium-binding adaptor
molecule 1 (Iba-1) (catalog number 019-19741; Wako
Chemicals, Richmond, Virginia, USA) or anti-glial fibrillary
acidic protein (GFAP) antibody (catalog number G9269;
Sigma-Aldrich, Saint Louis, MO, USA) solution followed
by secondary antibody tagged with Alexa Fluor 488
Table 2 Fatty acid content of diets




Lauric acid (12:0) 36.06 ± 0.80 35.29 ± 1.61
Myristic acid (14:0) 17.90 ± 0.17 16.64 ± 0.15
Palmitic acid (16:0) 11.35 ± 0.09 10.90 ± 0.19
Stearic acid (18:0) 12.06 ± 0.07 11.71 ± 0.20
Oleic acid (18:1n9) 3.85 ± 0.06 4.47 ± 0.16
Vaccenic acid (18:1n7) 0.26 ± 0.00 0.27 ± 0.01
Linoleic acid (18:2n6) 18.19 ± 0.47 17.19 ± 0.68
γ-Linolenic acid (18:3n6) N.D. 0.07 ± 0.06
Arachidonic acid (20:4n6) N.D. N.D.
α-Linolenic acid (18:3n3) 0.04 ± 0.04 3.08 ± 0.15
Docosahexaenoic acid (22:6n3) N.D. N.D.
Data are expressed as mean ± SD (n = 3)
N.D. not detected
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(Thermo Fisher, Waltham, MA, USA). The fluorescence
was visualized with a ×20 objective and quantified using
the MetaMorph software (Molecular Devices Inc., Sunny-
vale, CA, USA). Cells were counted in the peri-contusional
cortex in three non-overlapping fields per section and the
corresponding fields for the contralateral cortex.
Motor function tests
Motor deficits were assessed using the rotarod and beam
walk tests. Mice were trained to balance on an accelerat-
ing rotarod (0 to 400 rpm) for 5 min. The training
schedule began 4 days prior to the day of surgery and
consisted of three trials each day for 3 days with the
baseline performance recorded on the fourth day. The
mice were tested daily for 6 days after surgery, and the
average latency to fall over three trials on each day was
recorded. The beam walk test consisted of walking
across a 50-cm-long 0.7-cm-wide beam. The mice were
trained for 2 days with three trials per day followed by
recording the baseline performance on the day preced-
ing surgery. The total hind limb steps and foot slips were
counted on the day before surgery. The test was con-
ducted daily after surgery for 7 days.
Fear conditioning
The fear conditioning experiment was performed over
3 days starting 3 weeks after injury with the first day serving
as the day of habituation, the second as the day of fear con-
ditioning, and the third as the day of testing the memory.
Mice were individually placed inside the fear conditioning
chamber (Freeze Monitor, San Diego Instruments, San
Diego, CA, USA) on the first day and allowed to explore
for 5 min. On the following day, mice were given two
shocks at 120 and 150 s after being introduced into the fear
conditioning chamber and were taken out of the chamber
60 s after the last shock. Each shock was 0.5 mA and lasted
for 0.5 s. The mice were tested for fear memory 24 h after
the fear conditioning session by placing them again in the
fear conditioning chamber and assessing freezing for 5 min.
Freezing in mice was defined as the absence of any move-
ment except for breathing. Freezing was also monitored on
the first day to ascertain baseline freezing.
Statistical analyses
The data for behavioral tests were analyzed using repeated
measures two-way analysis of variance (ANOVA) with
Prism 6 for Windows (GraphPad software Inc., La Jolla,
CA, USA). Multiple comparisons between experimental
groups were made using Fisher’s least significant differ-
ence (LSD) test. Two-way ANOVA was also performed
for cytokine expression and microglial phenotype analyses;
Sidak’s multiple comparisons test was used for comparing
individual groups. Groups were compared for the fatty
acid analysis and astroglia immunofluorescence by un-
paired two-tailed Student’s t test.
Results
Mice on adequate ALA diet have higher DHA levels in the
brain
Higher levels of DHA, an endogenous product of ALA,
were found in the brain of mice on the diet having 3.1 %
ALA (Fig. 1) compared to those on the low ALA diet. The
average value of DHA was 50 % higher in the mice on ad-
equate ALA diet (14.23 ± 0.87 %) than in the mice on low
ALA diet (9.29 ± 0.64 %) (a). The increase in DHA was mir-
rored by a corresponding decrease in n-6 PUFAs including
arachidonic acid (AA; 20:4n-6) (8.54 ± 0.41 % vs 5.85 ±
0.45 %), n-6 docosatetraenoic acid (22:4n-6) (3.03 ± 0.14 %
vs 1.53 ± 0.12 %), and DPAn-6. The DPAn-6 level decreased
from 3.51 ± 0.3 % in the brain of low ALA diet mice to a
nearly undetectable level in the mice on adequate ALA diet.
As a consequence, the adequate ALA diet reduced the
DPAn-6 to DHA ratio from 0.38 ± to 0.05 to 0.01 ± 0.007 %
(b) and the AA to DHA ratio from 0.92 ± 0.04 to 0.41 ±
0.02 % (c).
Mice with higher brain DHA show less neuroinflammation
after TBI
The expression of pro-inflammatory cytokines TNF-α,
IL-1β, IL-6, CCL2, and the anti-inflammatory cytokine
IL-10 in the DHA-low and DHA-high brains was mea-
sured at 4 h, 24 h, and 4 days after TBI. TBI induced an
increase in all pro-inflammatory cytokines examined.
Two-way ANOVA revealed a significant elevation in the
expression of TNF-α (p < 0.0001), IL-1β (p < 0.0001), IL-
6 (p < 0.0001), and CCL2 (p = 0.0008) after TBI (Fig. 2).
The TBI-induced production of these cytokines was af-
fected by the brain DHA status. Sidak’s multiple com-
parisons test revealed significantly lower expression of
TNF-α (22.0 ± 1.8 vs 17.8 ± 2.4; p = 0.007) as well as IL-
1β transcript levels (50.0 ± 9.2 standard deviation (SD) vs
30.9 ± 5.5; p < 0.0001) in the adequate ALA diet group at
4 h after TBI. Similar differences were present for IL-6
(46.7 ± 5.3 vs 15.7 ± 3.6; p < 0.0001) and CCL2 (44.6 ± 6.2
vs 19.7 ± 2.9; p < 0.0001) at 24 h after TBI. The expres-
sion of the anti-inflammatory cytokine IL-10, despite its
elevation after TBI, was not significantly affected by diet
for any of the time points considered in this study. To
evaluate changes in protein expression, the CCL2 and
IL-1β expression was assessed by ELISA and western
blotting, respectively. CCL2 and IL-1β protein expres-
sion increased after TBI and remained elevated at all
time points examined (Fig. 3). Two-way ANOVA
showed significant effects for injury (p < 0.001) and diet
(p < 0.01) for both the cytokines. Sidak’s multiple com-
parisons test revealed a significant decrease in CCL2
expression at 24 h post-injury for mice on adequate
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ALA diet compared to mice on low ALA diet (p < 0.05)
(Fig. 3a). The expression of IL-1β protein was signifi-
cantly lower at 4 days after injury for the adequate ALA
diet mice compared to those on low ALA diet (p < 0.05)
(Fig. 3b).
Acute post-injury astrogliosis is modulated by n-3 PUFA
status without affecting microglial density
Iba-1 is expressed by microglia and macrophages. TBI
resulted in a threefold increase in the number of Iba-1-
positive cells around the contusion site compared to the
Fig. 1 Dietary α-linolenic acid increases brain docosahexaenoic acid content. a Lipid analysis of the brain samples of mice revealed that mice on
adequate α-linolenic acid (ALA) diet had more docosahexaenoic acid (DHA; 22:6n-3), less arachidonic acid (AA; 20:4n-6), n-6 docosatetraenoic acid
(22:4n-6), and n-6 docosapentaenoic acid (DPAn-6; 22:5n-6) in the brain compared to mice on low ALA diet. b, c Mice on adequate ALA diet had
lower ratio of DPAn-6 to DHA (b) as well as AA to DHA (c) compared to low ALA diet mice. n = 4 each. ***p < 0.001 vs low ALA diet group. Data
are expressed as mean ± SD
Fig. 2 a–e Suppression of TBI-induced acute inflammatory cytokine expression in mice with higher brain docosahexaenoic acid. TBI induced the
gene expression of pro-inflammatory cytokines in the cerebral cortex. Adequate α-linolenic acid (ALA) diet resulted in lower expression of
pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and CCL2 after TBI as compared to the low ALA group. n = 3–4. ***p < 0.001, **p < 0.01 compared
to the low ALA diet group for the respective time point. Data are expressed as mean ± SD
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contralateral cortex (Fig. 4a). However, there was no
significant difference in the number of Iba-1-positive
cells between the diet groups. The mean Iba-1-
positive cell count obtained from the contralateral
cortex was 119.4 ± 2.0 and 129.1 ± 15.9 for the low
ALA and adequate ALA diet group, respectively. In
the injured mouse brains, mean counts of Iba-1-
positive cells accumulated around the injury site were
349.3 ± 13.0 and 304.8 ± 17.7 for the low ALA and ad-
equate ALA diet groups, respectively. GFAP immuno-
reactivity in the contralateral cortex was negligible
(Fig. 4b). However, TBI induced a robust increase in
GFAP immunofluorescence, indicating astrocyte acti-
vation. Mice with DHA deficiency showed higher
GFAP immunofluorescence in the injured cortex (p < 0.01)
compared to the mice that had greater DHA (2.6 ± 0.1 vs
2.1 ± 0.1, respectively).
Altering the brain n-3 PUFA has limited effect on
microglial M1/M2 polarization
Since the microglial response to injury depends on
their phenotype, we assessed the expression of CD-16
and CD-32 for M1 microglia and CD-206, arginase 1
(Arg-1), and Ym1/2 for M2 microglia. TBI induced
distinct increases in the expression of all these
markers, particularly from 24 h (Fig. 5). However,
with the sole exception of CD-206, there was no sta-
tistically significant change in the relative expression
of these M1/M2 markers due to n-3 PUFA differ-
ences. The expression of CD-206 was higher in the
low ALA diet group (p < 0.05) (1.9 ± 0.1) at 24 h after
TBI compared to the adequate ALA group (1.1 ± 0.2).
Mice with more brain DHA exhibit better motor recovery
after TBI
TBI resulted in motor deficits observed in the rotarod as
well as beam walk tests (Fig. 6). Repeated two-way
ANOVA revealed a significant effect of diet on the la-
tency to fall off the rotarod (p < 0.01). The motor per-
formance of all mice recovered gradually with time. The
mean time on the rotarod for the mice on low ALA diet,
and thus with lower brain DHA, did not reach the pre-
injury levels even on the sixth day after injury (248 s ±
14.5 standard error of mean (SEM) compared to the
pre-injury time of 293 s ± 2 SEM) (Fig. 6a). However, the
performance of the mice on adequate ALA diet that
have more brain DHA was comparable to the pre-injury
level (288.6 ± 5.1 SEM) by the fifth day (277.2 ± 7.6
SEM). In the beam walk test, the mean values for foot
slips for the adequate ALA diet mice remained lower
than those of the low ALA group throughout the test
period as shown by the significant difference on day 2, 3,
4, and 6 after injury (p < 0.05) (Fig. 6b).
Contextual fear conditioning test was used to assess
differences in fear memory after TBI. The mice on ad-
equate ALA diet had significantly better memory 24 h
after the fear conditioning for both sham (p < 0.001) and
TBI animals (p < 0.01) compared to the low ALA group
as indicated by more freezing (Fig. 6c). However, TBI by
itself did not affect freezing.
Discussion
The present study investigated the effects of altering the
brain DHA status on acute TBI outcome. The DHA
level in mouse brains was modulated by differing levels
Fig. 3 a, b Suppression of traumatic brain injury-induced CCL2 and IL-1β protein expression in mice with higher brain docosahexaenoic acid.
Traumatic brain injury caused induction of CCL2 and IL-1β protein expression in the cerebral cortex at the site of injury. The expression of both
proteins was lower in mice on adequate α-linolenic acid (ALA) diet compared to the low ALA group. N = 3–4. *p < 0.05 compared to the low ALA
diet group for the respective time points. Data are expressed as mean ± SEM
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of dietary ALA from late gestation to the adult stage. A
moderately lower DHA level in the brain achieved by a
diet lacking DHA and having low ALA was to model hu-
man brains with conspicuous presence of DPAn-6 [4].
With this diet, DPAn-6 was elevated in mouse brains
with the DPAn-6 to DHA ratio of 0.38 (Fig. 1) which is
similar to that observed in human brains (0.44) [4]. The
brain DPA to DHA ratio below 0.01 that is normally ob-
served in an n-3 PUFA-sufficient condition [3] was also
achieved by providing 3.1 % ALA in diet.
Acute increase in inflammatory mediators is a part of
fundamental tissue response to injury. Decrease in n-3
PUFA levels with a corresponding increase in the n-6 to
n-3 PUFA ratio can lead to increase in inflammation
[21]. Phospholipase A2 is activated after TBI [22], which
elevates free fatty acid levels [23], leading to greater local
availability of DHA and AA. While eicosanoids gener-
ated from AA can be neurotoxic under pathological con-
ditions, docosanoids derived from DHA are often anti-
inflammatory. Having higher DHA levels in the brain
can lead to greater local free DHA levels after injury as
well as more anti-inflammatory DHA metabolites. These
attributes likely decreased acute inflammatory cytokine
expression after TBI in mice with higher brain DHA
(Fig. 2). The transcription factor nuclear factor kappa
light chain enhancer of activated B cells (NF-kB) that
upregulates the expression of pro-inflammatory genes
has been shown to be activated after TBI [24]. In con-
trast, DHA/EPA supplementation can reduce NF-kB ac-
tivity and inflammation, as shown for neonatal hypoxia-
ischemia [9] and LPS-stimulated macrophages [25]. In
addition, increase in oxidative stress in the injured brain
leads to generation of oxidation products of n-3 PUFA,
and these products can inhibit NF-kB by activating per-
oxisome proliferator-activated receptor (PPAR)α [26].
Thus, it is likely that raising the brain DHA level re-
duced pro-inflammatory cytokines by affecting the activ-
ity of these transcription factors.
ALA-rich diet was reported to lower the production of
IL-6, IL-1β, and TNF-α by peripheral blood mononuclear
cells of hypercholesterolemic subjects compared to con-
trols fed with either high linoleic acid diet or a typical
Fig. 4 Glial reactivity in mice on low or adequate α-linolenic acid diet after traumatic brain injury. a Traumatic brain injury (TBI) resulted in distinct
increase in Iba-1-positive cells in the peri-contusional cortex at 3 days post-injury. Diets producing different brain docosahexaenoic acid (DHA)
contents did not affect the density of Iba-1-positive cells at the injury site. b Cortical GFAP immunofluorescence increased 3 days after TBI was
more in mice on low α-linolenic acid (ALA) diet that have less brain DHA than the adequate ALA group. n = 3–4. **p < 0.01 vs control TBI. Data
are expressed as mean ± SEM. Scale bar 100 μm
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American diet [27]. These cytokines were also associated
with injury-induced activation of not only macrophage/
microglia but also astrocytes in the brain [28]. Pu et al.
[11] have reported increase in pro-inflammatory cytokine
expression along with an increase in microglia/macro-
phage count in n-3 PUFA-deficient mice after TBI. Our
results are in agreement with the local increase in pro-
inflammatory cytokines (Figs. 2 and 3). However, we did
not find significant differences in the macrophage/micro-
glial density around the injury site for the two diet groups
(Fig. 4a). This may be a result of the differences in dietary
n-3 PUFA used in the two studies. While we provided n-3
PUFA in the form of ALA in diet, Pu et al. [11] used fish
oil (1.5 % DHA and EPA). This may change the blood
levels of DHA/EPA that can impact the microglia activa-
tion after TBI. In addition, we had the mice on diet since
Fig. 5 Diets differing in α-linolenic acid content have limited effects on microglial polarization. The expression of M1 microglia/macrophage
markers CD-16 and CD-32 (a, b) and M2 microglia/macrophage markers CD-206, Arg-1, and Ym1/2 (c-e) was increased in peri-contusional cortex
after traumatic brain injury. Dietary α-linolenic acid (ALA) content showed no effect on the expression of these markers in general, with the excep-
tion of CD-206 at 24 h after TBI. n = 3–4. *p < 0.05 vs low ALA at the same time points. Data are expressed as mean ± SD
Fig. 6 Effect of low or adequate α-linolenic acid diet on motor and cognitive changes after TBI. a, b Impaired motor performance in the rotarod
(a) and beam walk tests (b) due to TBI was recovered faster in mice on adequate α-linolenic acid (ALA) diet compared to those on the low ALA
diet that had less brain DHA. c Mice on adequate ALA diet showed more freezing after contextual fear conditioning compared to the mice on
low ALA diet for both sham and TBI mice. ***p < 0.001, **p < 0.01, *p < 0.05 compared to the respective low ALA diet group. Data are expressed
as mean ± SEM. n = 8–14
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late gestation, while in the study by Pu and colleagues, the
mice were placed on diet at 3 weeks age. This is probably
the reason for greater differences in brain DHA (about
35 % change) in our experiment as compared to the small
but statistically significant changes of 10–15 % in the re-
ported study. Furthermore, the DPAn-6 levels change dra-
matically with our dietary regiment but do not change in
the case of Pu et al.’s study [11]. This is expected as the
brain undergoes rapid accretion of DHA during early de-
velopment when our dietary regimen was initiated while
its levels recover at a slower rate after adolescence [3].
These factors may also account for the temporal differ-
ences in cytokine expression in these studies. Pu et al.
assessed cytokine expression at 24 h post-injury and found
significant differences between the two diet groups for
TNF-α and IL-1β, while we found maximum expression
and significant differences for these cytokines at 4 h in our
time course analysis (Fig. 2). Nevertheless, we did observe
changes in CCL2 and IL-1β protein expression at 24 h
and 4 days, respectively (Fig. 3). Although we did not find
a significant difference in the macrophage/microglial
density near the injury site, there may also exist qualitative
changes in these cells priming them toward a pro- or anti-
inflammatory phenotype. The activated microglia/macro-
phages are categorized into a classical activated state or
M1 and an alternate activated state or M2. M1 microglia/
macrophages typically have a pro-inflammatory phenotype
producing pro-inflammatory cytokines, having increased
interaction with other immune cells, and contributing to
oxidative/nitrosative stress [29]. On the other hand,
M2 microglia/macrophages modulate phagocytosis
and promote wound healing [29, 30]. We did not find
any significant change in the M1/M2 phenotype
marker expression for activated macrophage/microglia
in the injured diet groups (Fig. 5). These findings sug-
gest that the DHA-derived changes in inflammation
may not be attributed to microglial activation at least
in our experimental settings using ALA as the n-3
PUFA source.
Our data indicated increased induction of astrogliosis
after TBI (Fig. 4b). Astrocyte activation is a complex
process that can aid in limiting inflammation [31]. How-
ever, it can also lead to localized pro-inflammatory envir-
onment. For example, activation of astrocytes by TLR4
stimulation can lead to pro-inflammatory cytokine ex-
pression [32]. In contrast to microglial activation, astro-
gliosis was significantly increased in the DHA-depleted
mouse brain. CCL2, which is mostly produced by astro-
cytes in the brain [33, 34], was significantly increased at
4 h after injury, indicating early activation of astrocytes.
The brains from the mice on ALA adequate diet showed
significantly reduced CCL2 at 24 h after injury compared
to the low ALA diet group. It is possible that sup-
pressed astrocyte activation with an increase in brain
DHA in the adequate ALA diet mice (Fig. 4b) may
have contributed to the reduction in CCL2 at 24 h of
injury. DHA inhibits endoplasmic reticulum stress in
astrocytes in the in vitro ischemia model [35] and re-
duces endoplasmic reticulum stress after TBI [36].
Thus, reduction in endoplasmic reticulum stress in
the mice on adequate ALA diet may have reduced
astrocyte activation after TBI.
Severe DHA depletion in the brain brought about by
multi-generational n-3 PUFA dietary restriction causes
significant impairment in functional recovery after TBI
[16]. Similarly, a relatively moderate lowering in brain
DHA levels also impaired motor recovery from TBI
(Fig. 6a, b). It is possible that neuroinflammation aggra-
vated by DHA deficiency contributed to the worse re-
covery outcome, although causal relationship still needs
to be established. The increase in brain DHA can be re-
sponsible for the increase in contextual fear learning/
memory (Fig. 6c) as DHA/n-3 PUFA is known to im-
prove cognition, although this parameter was not re-
sponsive to TBI.
Conclusions
Using a mouse model with brain DHA depletion, we
demonstrate that increasing brain DHA can limit post-
injury inflammation, reduce astrocyte activation, and im-
prove functional recovery. This study suggests possible
improvement of functional outcome by increasing brain
DHA through diet in human TBI.
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